Investing in biopharmaceutical companies that focus on the research, development, and commercialization of novel therapies for unmet medical needs.

Identifying and supporting companies that improve efficiency and transparency within the pharmaceutical supply chain, ensuring the timely and cost-effective delivery of medications.

Focusing on companies that develop and implement precision medicine solutions, tailoring treatment plans based on individual patient profiles and genetic information.